1. MicroRNA-16 mediates the regulation of a senescence-apoptosis switch in cutaneous T-cell and other non-Hodgkin lymphomas
- Author
-
Mitsugu Ito, I Toyota, N Hasunuma, Naoto Takahashi, Makoto Sugaya, Sho Ikeda, Kazuaki Teshima, Tomomitsu Miyagaki, Akihiro Kitadate, and Hiroyuki Tagawa
- Subjects
0301 basic medicine ,Senescence ,Cyclin-Dependent Kinase Inhibitor p21 ,Cancer Research ,medicine.drug_class ,T cell ,Blotting, Western ,Transplantation, Heterologous ,Apoptosis ,Mice, SCID ,Biology ,Hydroxamic Acids ,03 medical and health sciences ,Mice, Inbred NOD ,hemic and lymphatic diseases ,Cell Line, Tumor ,microRNA ,Genetics ,medicine ,Animals ,Humans ,Molecular Biology ,Vorinostat ,Cellular Senescence ,Mice, Knockout ,Polycomb Repressive Complex 1 ,Reverse Transcriptase Polymerase Chain Reaction ,Lymphoma, Non-Hodgkin ,Histone deacetylase inhibitor ,Cell cycle ,medicine.disease ,Lymphoma ,Lymphoma, T-Cell, Cutaneous ,Gene Expression Regulation, Neoplastic ,Histone Deacetylase Inhibitors ,MicroRNAs ,030104 developmental biology ,medicine.anatomical_structure ,BMI1 ,Immunology ,Cancer research ,Female ,RNA Interference ,Tumor Suppressor Protein p53 ,medicine.drug - Abstract
Multiple sequential genetic and epigenetic alterations underlie cancer development and progression. Overcoming cellular senescence is an early step in cancer pathogenesis. Here, we demonstrate that a noncoding regulatory RNA, microRNA-16 (miR-16), has the potential to induce cellular senescence. First, we examined the expression of miR-16 in primary cutaneous T-cell lymphoma (CTCL) and other non-Hodgkin T/natural killer (NK)-cell lymphomas and found that miR-16 was downregulated than that in the corresponding normal cells. Notably, miR-16 expression was reduced as the primary CTCL progressed from the early stage to the advanced stage. Next, we transduced CTCL cells with miR-16 to examine whether this miRNA exhibited tumor-suppressive effects in CTCL cells. In CTCL cells expressing wild-type p53, forced expression of miR-16 enhanced p21 expression via downregulation of the polycomb group protein Bmi1, thereby inducing cellular senescence. Alternatively, in CTCL cells lacking functional p53, miR-16 induced compensatory apoptosis. The miR-16 transfection significantly decreased senescent cells and increased apoptotic cells in p21-knockdown CTCL cells expressing wild-type p53, suggesting that the presence or absence of p21 may be the most important condition in the senescence-apoptosis switch in CTCL lymphomagenesis. Furthermore, we found that the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) restored the expression of miR-16 and its essential targets, induced senescence in CTCL cells expressing wild-type p53 and promoted apoptosis in cells with nonfunctional p53. Moreover, we found that other T/NK-cell lymphoma cell lines showed similar tumor-suppressive effects in response to miR-16 and SAHA and that these effects were dependent on p53 status. These results suggested that epigenetic silencing of miR-16 may be a key step during lymphoma development. Elucidation of the essential targets of miR-16 and SAHA provides a basis for the clinical application of SAHA in the treatment of CTCL and other non-Hodgkin T/NK-cell lymphomas.
- Published
- 2015